Document is current
Any future updates will be listed below
-
Authors
Lee, So Young
Prieto-Fernández, Endika
Egia-Mendikute, Leire
Antoñana-Vildosola, Asier
Velasco-Beltrán, Paloma
Bosch, Alexandre
Jimenez-Lasheras, Borja
de Blas, Ander
Etxaniz-Diaz de Durana, Jone
Valdaliso-Díez, Eunate
Bozal-Basterra, Laura
Ercilla, Amaia
Martin, José Ezequiel
Carracedo, Arkaitz
Gros, Alena
Aransay, Ana M.
Palazón, Asís
Pérez-Gutiérrez, Lorena https://orcid.org/0000-0001-8135-4975
-
Funding
Funding for this research was provided by:
FP7 Ideas: European Research Council (ERC-2018-StG 804236-NEXTGEN-IO)
Fundación Científica Asociación Española Contra el Cáncer (LABAE211744PALA, TALEN245896PERE, PRDVZ19003BOSC, PRDVZ21640DEBL)
Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona (LCF/PR/HR21/52410009, LCF/BQ/DR20/11790022)
Ministerio de Ciencia e Innovación (JDC2022-048612-I, RYC2021-031213-I, PRE2020-092342, PRE2022-104817, PREP2022-000848, RYC2018-024183-I)
Eusko Jaurlaritza (PRE_2019_1_0320)
Instituto de Salud Carlos III (MS15/00058)
- License Information
-
More Information
Article History
Received: 8 August 2024
Revised: 10 January 2025
Accepted: 6 March 2025
First Online: 7 April 2025
Declarations
:
: Buffy coats were provided by the Basque Biobank () with appropriate approval of the Ethical and Scientific Committees (code CEIC E19-75).
: A.G. is a member of the scientific advisory board (SAB) of Achilles Therapeutics plc, SingulaBIO, RootPath, Inc., BioNTech SE, and consults is a consultant advisor for Instil BIo. AG is co-inventor of patents licensed and with royalties E-059-2013/0 E-085-2013/0, E-149-2015/0. The rest of the authors declare no potential conflicts of interest.
